Leukemia, Myeloid
Showing 6226 - 6250 of 6,958
Acute Myelogenous Leukemia, Myeloid Leukemia in Remission, Effects of Immunotherapy Trial in Brussels (Recombinant WT1
Unknown status
- Acute Myelogenous Leukemia
- +2 more
- Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic (ASCI)
-
Brussels, BelgiumInstitut Jules Bordet, tumor center of the Universite Libre de B
Jan 19, 2012
Leukemia Trial in Tampa (Cytarabine, Daunorubicin, Etoposide)
Completed
- Leukemia
- Cytarabine
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Sep 24, 2012
Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis Trial in Rochester (tipifarnib, laboratory biomarker
Completed
- Essential Thrombocythemia
- +2 more
- tipifarnib
- laboratory biomarker analysis
-
Rochester, MinnesotaMayo Clinic
Jun 3, 2013
Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Germany (5-Azacitidine)
Completed
- Myelodysplastic Syndrome
- Acute Myeloid Leukemia
-
Heidelberg, Baden-Wuertemberg, Germany
- +5 more
Jan 20, 2012
Acute Myelogenous Leukemia, GVHD, Acute Lymphoblastic Leukemia Trial in Boston (sirolimus, tacrolimus)
Completed
- Acute Myelogenous Leukemia
- +6 more
-
Boston, MassachusettsDana-Farber Cancer Center
Jan 24, 2012
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Chicago (tipifarnib)
Completed
- Chronic Myeloproliferative Disorders
- +4 more
-
Chicago, IllinoisUniversity of Chicago Cancer Research Center
Feb 8, 2013
Leukemia, Myeloid, Chronic Trial (Database)
Unknown status
- Leukemia, Myeloid, Chronic
- Database
- (no location specified)
Dec 11, 2011
Non-Hodgkin's Lymphoma, Hodgkin Lymphoma, Multiple Myeloma Trial (BMS-936559 (Anti PD-L1))
Withdrawn
- Non-Hodgkin's Lymphoma
- +3 more
- BMS-936559 (Anti PD-L1)
- (no location specified)
Feb 22, 2012
Cancer Trial in New York (caspofungin acetate, liposomal amphotericin B)
Completed
- Cancer
- caspofungin acetate
- liposomal amphotericin B
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jan 17, 2013
Leukemia, Lymphoma Trial in United States (dolastatin 10)
Completed
- Leukemia
- Lymphoma
- dolastatin 10
-
Baltimore, Maryland
- +3 more
Jun 25, 2013
Leukemia, Lymphoma Trial in Houston (laromustine)
Completed
- Leukemia
- Lymphoma
-
Houston, TexasM.D. Anderson Cancer Center at University of Texas
Jul 17, 2013
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Saint Louis (arsenic trioxide, tretinoin)
Terminated
- Leukemia
- +3 more
- arsenic trioxide
- tretinoin
-
Saint Louis, MissouriWashington University Barnard Cancer Center
Feb 4, 2013
Genes in Samples From Younger Acute Lymphoblastic Leukemia
Unknown status
- Leukemia
- DNA analysis
- +7 more
- (no location specified)
Jul 9, 2013
Anemia, Leukemia, Lymphoma Trial in United States (epoetin alfa, quality-of-life assessment)
Completed
- Anemia
- +3 more
- epoetin alfa
- quality-of-life assessment
-
Berkeley, California
- +17 more
Jul 1, 2013
Leukemia Trial in Puerto Rico, South Africa, United States (arsenic trioxide)
Completed
- Leukemia
- arsenic trioxide
-
Scottsdale, Arizona
- +70 more
Jun 20, 2013
Depression, Fatigue, Leukemia Trial in Chapel Hill (Resting vitals, Body Composition, Timed Get-up and Go test (TGUG).)
Completed
- Depression
- +4 more
- Resting vitals
- +5 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Mar 5, 2012
Lymphoma, Radiation Toxicity Trial run by the NCI (pentetic acid calcium, yttrium Y 90 daclizumab)
Completed
- Lymphoma
- Radiation Toxicity
- pentetic acid calcium
- yttrium Y 90 daclizumab
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 19, 2013
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitts Leukemia/Lymphoma Trial in Valhalla (CLAG-M)
Unknown status
- Acute Lymphoblastic Leukemia
- +3 more
-
Valhalla, New YorkWestchester Medical Center/New York Medical College
Jan 19, 2012